Chevron Pharma Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 07-07-2024
- Paid Up Capital ₹ 4.50 M
as on 07-07-2024
- Company Age 14 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.44 Cr
as on 07-07-2024
- Satisfied Charges ₹ 4.50 Cr
as on 07-07-2024
- Revenue -6.78%
(FY 2023)
- Profit -69.75%
(FY 2023)
- Ebitda -46.20%
(FY 2023)
- Net Worth 5.36%
(FY 2023)
- Total Assets -21.89%
(FY 2023)
About Chevron Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.50 M.
The company currently has active open charges totaling ₹9.44 Cr. The company has closed loans amounting to ₹4.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Karan Jakasaniya, Umesh Mendapara, Rameshbhai Gabani, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24100GJ2010PTC061749
- Company No.
061749
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Jul 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ankleshwar, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Chevron Pharma?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Umesh Mendapara  | Director | 28-Dec-2010 | Current |
| Karan Jakasaniya | Director | 19-Mar-2018 | Current |
| Rameshbhai Gabani | Director | 27-Jul-2010 | Current |
| Pravin Teraiya | Director | 28-Dec-2010 | Current |
| Uramilaben Teraiya | Director | 28-Dec-2010 | Current |
| Harshaben Jakasaniya | Director | 01-May-2019 | Current |
Financial Performance of Chevron Pharma.
Chevron Pharma Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 6.78% decrease. The company also saw a substantial fall in profitability, with a 69.75% decrease in profit. The company's net worth moved up by a moderate rise of 5.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chevron Pharma?
In 2023, Chevron Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Apex Healthcare LimitedActive 17 years 11 monthsUmesh Mendapara and Rameshbhai Gabani are mutual person
Ankleshwar Research And Analytical Infrastructure AssociationActive 19 years 6 monthsRameshbhai Gabani is a mutual person
Amsal-Chem Private LimitedActive 32 years 3 monthsUmesh Mendapara and Rameshbhai Gabani are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 04 May 2018 | ₹4.72 Cr | Open |
Axis Bank Limited Creation Date: 06 Mar 2018 | ₹4.72 Cr | Open |
Bank Of Baroda Creation Date: 08 Jun 2015 | ₹1.50 Cr | Satisfied |
How Many Employees Work at Chevron Pharma?
Chevron Pharma has a workforce of 57 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chevron Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chevron Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
